Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q3 2017 · 10-Q
Revenue$0.00$0.00— vs Q3 2016 Net Income-$2.47M-$2.47MN/M vs Q3 2016 EPS Diluted-$0.25-$0.25N/M vs Q3 2016 Operating Income-$2,476,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,529,000N/M ended Sep 30, 2017 · filed Nov 9, 2017 · 40 d after period end